May.4th is 5 years’ founding anniversary of Angine, and Angine "Health & Pharma Partner" (HPP) Alliance & Innovation Center Opened was also opened in Hangzhou on the day to address the past 5 years achievement made as well as the new projection for the next 10 years and more.
By 5 years’ effort from Angine team and venture partners, Angine has established the following defined biz model and four business platforms by focusing on the life sciences companies’ global business development/partnership building and investment/incubation in the bio/pharma/device fields.
For the newly established Angine "Health & Pharma Partner" (HPP) Alliance & Innovation Center, the following services will be provided to the HPP Alliance member and Angine’s overseas strategic business partner and clients served.
l Product and Project Promotion by Established 6 Events Brand and Database for the Cross-Border Biz
ü 6 brand events related with the cross-border international business and BD partnership in the life science industry was established by partnering with CPhi China, China Pharmaceutical Enterprise Association, China OTC Association ect. and the data related with cross-border business as well as Chinese potential clients could be provided for the tailor-made BD solutions to Angine’s clients.
ü By the established database for the Chinese pharma market and companies’with the global competitive strengths in the specified therapeutic field, the deep market study and investigation could be conducted to meet clients’ real needs before initiating the partnership or investment in China.
ü Arranging the 1 to 1 on-line meetings and the visit to the potential business or invest partner as overseas clients’China “virtual office” representatives.
l Overseas’ Market Access & BD Partnership Consulting services
ü China market access and BD partnership strategy evaluation and consulting (tailor-made service);
ü Jointly introduce the valuable innovative projects in the clinical stage and the launched product (License-in) from the overseas’ innovative (bio)pharma and device company to China, also assisting the Chinese companies with the global competitive strengths in the specified therapeutic field to license-out some of the pipeline with the global standard innovation and data to the overseas’ partners.
l Investment & Incubation and Joint Development of Innovative Projects
ü Empowering medical and health innovation projects (drug, device, and digital tools etc) developed in China and abroad by working together with the fund partnering with Angine.
ü Angine Venture which is under establishment will work together with the oversea’ innovative companies to co-develop the Chinese market by investment and incubation.
For the overseas companies in the life science field which would like to explore the Chinese market and build the strategic partnership with the Chinese companies, and you are welcomed to visit Angine "Health & Pharma Partner" Innovation Center in Hangzhou, and you also can write the email to Angine via bd@anginebio.com to explore the partnership opportunities together.